Telix Pharmaceuticals Limited (TLPPF)
USD 15.71
(0.0%)
USD 15.71
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 314.39 Million AUD | 233.36% |
| 2022 | 94.42 Million AUD | 3918.21% |
| 2021 | 2.35 Million AUD | -11.52% |
| 2020 | 2.65 Million AUD | 181.95% |
| 2019 | 942 Thousand AUD | 382.73% |
| 2018 | 195.14 Thousand AUD | 5244.79% |
| 2017 | -3793.00 AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 115.52 Million AUD | -66.37% |
| 2024 Q2 | 110.33 Million AUD | 64.44% |
| 2023 FY | 314.78 Million AUD | 233.36% |
| 2023 Q3 | 86.66 Million AUD | -4.56% |
| 2023 Q2 | 90.81 Million AUD | 44.58% |
| 2023 Q4 | 223.97 Million AUD | 158.43% |
| 2023 Q1 | 62.81 Million AUD | 39.92% |
| 2022 Q3 | 40.72 Million AUD | 361.52% |
| 2022 Q4 | 44.89 Million AUD | 10.23% |
| 2022 FY | 94.42 Million AUD | 3918.21% |
| 2022 Q1 | 6.73 Million AUD | 135.74% |
| 2022 Q2 | -15.57 Million AUD | -331.06% |
| 2021 Q4 | -18.85 Million AUD | -1351.78% |
| 2021 Q3 | 1.5 Million AUD | 113.48% |
| 2021 FY | 2.35 Million AUD | -11.52% |
| 2021 Q2 | -11.17 Million AUD | -1198.38% |
| 2021 Q1 | 1.01 Million AUD | 112.33% |
| 2020 Q3 | 1.24 Million AUD | 114.49% |
| 2020 FY | 2.65 Million AUD | 181.95% |
| 2020 Q4 | -8.25 Million AUD | -760.5% |
| 2020 Q2 | -8.62 Million AUD | -2599.71% |
| 2020 Q1 | 345 Thousand AUD | 106.05% |
| 2019 Q3 | -73 Thousand AUD | 98.82% |
| 2019 FY | 942 Thousand AUD | 382.73% |
| 2019 Q4 | -5.7 Million AUD | -7714.43% |
| 2019 Q1 | 544 Thousand AUD | 457.95% |
| 2019 Q2 | -6.17 Million AUD | -1234.28% |
| 2018 Q3 | 97.5 Thousand AUD | 0.0% |
| 2018 Q4 | 97.5 Thousand AUD | 0.0% |
| 2018 FY | 195.14 Thousand AUD | 5244.79% |
| 2018 Q1 | - AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2017 FY | -3793.00 AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 Q3 | - AUD | 0.0% |
| 2017 Q1 | - AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | -1996.073% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -10134974.146% |
| SQZ Biotechnologies Company | 9.79 Million USD | -3110.027% |
| Evofem Biosciences, Inc. | 11.7 Million USD | -2585.717% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | -163.955% |
| Mesoblast Limited | -35.16 Million USD | 993.966% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 920714.934% |
| Genus plc | 178.7 Million USD | -75.932% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -76549.641% |
| Marizyme, Inc. | 457.7 Thousand USD | -68588.798% |
| ContraFect Corporation | -154 Thousand USD | 204249.351% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 2858190.909% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 628880.0% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -409469.964% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -478219.742% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 81232.694% |
| MultiCell Technologies, Inc. | 49.32 USD | -637449210.624% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | -680.802% |
| EV Biologics, Inc. | 48.9 Thousand USD | -642824.335% |
| Q BioMed Inc. | -8988.00 USD | 3497986.07% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | -1012.688% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 2038416.909% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 220.1 Million USD | -42.837% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -449028.571% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 253128.145% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -505138.968% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 6348847.981% |
| Arch Therapeutics, Inc. | -2439.00 USD | 12890218.901% |
| IMV Inc. | -962.29 Thousand USD | 32770.753% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | -223665.125% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 322501.682% |
| GB Sciences, Inc. | -624.00 USD | 50383112.821% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 365550.783% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 7.56 Billion USD | 95.842% |
| Halberd Corporation | -208.00 USD | 151149138.462% |
| Enzolytics Inc. | 30.7 Thousand USD | -1023704.872% |
| Resverlogix Corp. | - USD | -Infinity% |
| Affymax, Inc. | 1.35 Million USD | -23065.577% |
| SYBLEU INC | 11.69 Thousand USD | -2687912.996% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | -65067.598% |
| argenx SE | 1.1 Billion USD | 71.638% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 1318.66% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -50822.926% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 23.236% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 3550122.584% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | -608.759% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 27640.094% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | -31721.462% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | -3171.148% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 375047.823% |
| BioStem Technologies, Inc. | 15.42 Million USD | -1938.205% |
| ONE Bio Corp. | 20.12 Million USD | -1462.152% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 2656542.755% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 651563.976% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -177964.114% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -177964.114% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 61204.74% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | -630.13 Thousand USD | 49992.246% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 1084203.448% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | -69757.769% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 98498.47% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | -6722.7% |
| Bioxytran, Inc. | -8285.00 USD | 3794789.197% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 84386.863% |
| Neutra Corp. | 14.33 Thousand USD | -2193063.586% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 383502.439% |
| PureTech Health plc | -1.6 Million USD | 19712.601% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 31500.189% |
| IXICO plc | 3.27 Million USD | -9514.373% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 45401.153% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 17653.881% |
| CSL Limited | 7.7 Billion USD | 95.92% |
| Cellectis S.A. | 18 Thousand USD | -1746511.111% |